chr5-56111642-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_024669.3(ANKRD55):c.1106G>A(p.Arg369Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000515 in 1,553,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_024669.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD55 | NM_024669.3 | c.1106G>A | p.Arg369Gln | missense_variant | 10/12 | ENST00000341048.9 | |
ANKRD55 | XM_047417710.1 | c.620G>A | p.Arg207Gln | missense_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD55 | ENST00000341048.9 | c.1106G>A | p.Arg369Gln | missense_variant | 10/12 | 2 | NM_024669.3 | P1 | |
ANKRD55 | ENST00000434982.2 | c.242G>A | p.Arg81Gln | missense_variant | 2/4 | 1 | |||
ANKRD55 | ENST00000504958.6 | c.977G>A | p.Arg326Gln | missense_variant | 8/10 | 5 | |||
ANKRD55 | ENST00000505970.2 | n.789G>A | non_coding_transcript_exon_variant | 7/7 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000519 AC: 1AN: 192598Hom.: 0 AF XY: 0.00000983 AC XY: 1AN XY: 101756
GnomAD4 exome AF: 0.00000500 AC: 7AN: 1400900Hom.: 0 Cov.: 33 AF XY: 0.00000723 AC XY: 5AN XY: 692018
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at